Article

2015: The Year in Multiple Sclerosis News

Author(s):

Davy James, Managing Editor

Most read multiple sclerosis articles from the past year.

[<a href="//storify.com/pharmacytimes/2015-the-year-in-multiple-sclerosis-news" target="_blank">View the story "2015: The Year in Multiple Sclerosis News" on Storify</a>]

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Chronic kidney disease (CKD) -- Image credit: Kiattisak | stock.adobe.com
June 12th 2025

Finerenone and Empagliflozin Outperform Either Treatment Alone in Patients With CKD

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacists Take the Lead on Advanced Therapeutics
June 9th 2025

Pharmacists Take the Lead on Advanced Therapeutics

Aislinn Antrim, Managing Editor
Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development
August 23rd 2024

Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

Ashley Gallagher, Editor
Op-Ed: Expand Patient Choice to Lower Medication Costs
June 6th 2025

Op-Ed: Expand Patient Choice to Lower Medication Costs

Colin Edgerton, MD
Infusion management: Close-up of a butterfly cannula
June 6th 2025

SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity

Luke Halpern, Assistant Editor